Stockreport

This Cancer Biotech Stock Just Averted A Patent Disaster In Europe [Investor's Business Daily]

Clovis Oncology, Inc.  (CLVS) 
Last clovis oncology, inc. earnings: 2/24 04:05 pm Check Earnings Report
PDF Related news Clovis Oncology stock jumped Tuesday after a European patent decision averted a "worst case" scenario for its ovarian cancer treatment, Rubraca. In morning [Read more]